Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.62 - $2.03 $59,940 - $75,110
-37,000 Reduced 15.98%
194,500 $340,000
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.85 $263,736 - $463,980
-162,800 Reduced 41.29%
231,500 $384,000
Q1 2024

May 15, 2024

SELL
$1.6 - $2.48 $581,867 - $901,894
-363,667 Reduced 47.98%
394,300 $973,000
Q4 2023

Feb 14, 2024

SELL
$1.66 - $2.41 $136,012 - $197,463
-81,935 Reduced 9.76%
757,967 $1.74 Million
Q3 2023

Nov 15, 2023

BUY
$1.55 - $3.31 $1.3 Million - $2.78 Million
839,902 New
839,902 $2.01 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $905M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.